Home » Topics » BioWorld Science

BioWorld Science
RSS

Exclusive worldwide rights offered for human full-length TRK-B

Nov. 28, 1996

Diagnostic kits for beta-thalassemia available for licensing

Nov. 28, 1996

Purified or recombinant TAP 29 with anti-HIV activity available for licensing

Nov. 28, 1996

Zeneca submits antimigraine Rx for approval

Nov. 28, 1996

Antimicrobial ranalexin peptides available for licensing

Nov. 28, 1996

Disappointing results reported for genital herpes vaccine

Nov. 28, 1996

rhBMP-2 cleared for limited clinical trial for spine fusion

Nov. 28, 1996

Cortecs, Inflazyme collaborate on tests for TB

Nov. 28, 1996

Asian distribution agreement signed for Advanced Magnetics' liver contrast agent

Nov. 28, 1996

Merck & Co. reports nonpeptide fibrinogen antagonists with oral activity

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...